NCT06202274View on ClinicalTrials.gov

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

NAActive, not recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

October 4, 2023

Primary Completion Date

October 4, 2028

Study Completion Date

October 4, 2029

Conditions
Hair ReductionTattoo RemovalWrinkleAcneScarsBenign Cutaneous Vascular LesionsSkin Conditions
Interventions
DEVICE

Nordlys, Gentle, Picoway, Vbeam, Profound, Profound Matrix, eTwo, Exceed, CO2RE

Subjects will receive up to twelve (12) treatments at minimum treatment interval of 2 weeks and maximum treatment interval of 12 weeks.

Trial Locations (3)

20692

Yokneam Candela Clinic, Yokneam Illit

32207

Center for Morden Aesthetic Medicine, Jacksonville

01752

Candela Institue for Excellence, Marlborough

Sponsors
All Listed Sponsors
lead

Candela Corporation

INDUSTRY